HER2 Support Group Forums - View Single Post - more on risks associated with G-CSF and GM-CSF which support White blood cells wchemo

AlaskaAngel · 07-18-2009, 06:43 PM

If the study was done, as stated, on "women aged 65 years or older in the Surveillance, Epidemiology, and End Results-Medicare database who were diagnosed with stages I-III breast cancer from January 1, 1991, to December 31, 1999, we identified those who received G-CSF or GM-CSF concurrently with chemotherapy." then the conclusions from it are based on subjects who completed treatment several years before dose-dense therapies led to even much more common use of these drugs.

AlaskaAngel

07-18-2009, 06:43 PM	#6
AlaskaAngel Senior Member Join Date: Sep 2005 Location: Alaska Posts: 2,018	Learn and live If the study was done, as stated, on "women aged 65 years or older in the Surveillance, Epidemiology, and End Results-Medicare database who were diagnosed with stages I-III breast cancer from January 1, 1991, to December 31, 1999, we identified those who received G-CSF or GM-CSF concurrently with chemotherapy." then the conclusions from it are based on subjects who completed treatment several years before dose-dense therapies led to even much more common use of these drugs. AlaskaAngel